Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Eptacog alfa (activated)

EU orphan designation number: EU/3/05/333   
Active ingredient: Eptacog alfa (activated)
Indication: Treatment of diffuse alveolar haemorrhage
Sponsor: Pharmaorigin ApS
c/o Serendex ApS, Cobis Building, Ole Maaløes vej 3, DK-2200 København, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2005 Centralised Orphan - Designation EMEA/OD/063/05 (2005)5629 of 14/12/2005
04/04/2007 Other procedure -
21/05/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/063/05/T/01 (2007)2168 of 14/05/2007
08/04/2008 Other procedure -
24/11/2008 Other procedure -
17/02/2010 Other procedure -